"成長戦略の設計は私たちのDNAにあります"

血管拡張性ショック治療用バソプレッシン市場規模・シェア・COVID-19影響分析、用途別（敗血症、心臓手術後その他）、地域別予測（2020-2027年）

最終更新: November 17, 2025 | フォーマット: PDF | 報告-ID: FBI104065

 

私たちはお客様の研究目標に合わせてレポートをカスタマイズし、競争上の優位性を獲得し、十分な情報に基づいた意思決定を行えるように支援します。

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Recent Industry Developments Such as Mergers & Acquisitions
    2. Regulatory Scenario for Key Countries
    3. New Product Launch
    4. Statistics on Prevalence of Cardiac Disorders for Key Countries/Regions
    5. Pipeline Analysis
  5. Global Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country
      1. U.S.
      2. Canada     
  7. Europe Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Endo International plc
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. AMOMED Pharma
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      3. La Jolla Pharmaceutical Company
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      4. Pfizer Inc.
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      5. Ferring Pharmaceuticals
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      6. Fresenius Kabi Canada
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      7. Astellas Pharma
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      8. Eagle Pharmaceuticals, Inc.
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      9. Others
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Recent Industry Developments Such as Mergers & Acquisitions
    2. Regulatory Scenario for Key Countries
    3. New Product Launch
    4. Statistics on Prevalence of Cardiac Disorders for Key Countries/Regions
    5. Pipeline Analysis
  5. Global Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country
      1. U.S.
      2. Canada     
  7. Europe Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Vasopressin for Vasoplegic Shock Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast - By Application
      1. Sepsis
      2. Post Cardiac Surgery
      3. Others
    3. Market Analysis, Insights and Forecast - By Country/Sub Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Endo International plc
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. AMOMED Pharma
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      3. La Jolla Pharmaceutical Company
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      4. Pfizer Inc.
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      5. Ferring Pharmaceuticals
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      6. Fresenius Kabi Canada
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      7. Astellas Pharma
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      8. Eagle Pharmaceuticals, Inc.
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      9. Others
        1. Overview
        2. Products & services
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
もっと読む

Figure 1:  Global Vasopressin for Vasoplegic Shock Market Revenue Breakdown (US$ Mn, %) by Region, 2019 & 2027
Figure 2:  Global Vasopressin for Vasoplegic Shock Market Value Share (%), by Application, 2019 & 2027
Figure 3:  Global Vasopressin for Vasoplegic Shock Market Forecast (US$ Mn), by Sepsis, 2016-2027
Figure 4:  Global Vasopressin for Vasoplegic Shock Market Forecast (US$ Mn), by Post Cardiac Surgery,2016-2027
Figure 5:  Global Vasopressin for Vasoplegic Shock Market Forecast (US$ Mn), by Others,2016-2027
Figure 6:  Global Vasopressin for Vasoplegic Shock Market Value (US$ Mn), by Region, 2019 & 2027
Figure 7:  North America Vasopressin for Vasoplegic Shock Market Value (US$ Mn), by Application, 2019 & 2027
Figure 8:  North America Vasopressin for Vasoplegic Shock Market Value Share (%), by Application, 2019
Figure 9:  North America Vasopressin for Vasoplegic Shock Market Value (US$ Mn), By Country, 2019 & 2027
Figure 10:  North America Vasopressin for Vasoplegic Shock Market Value Share (%), By Country, 2019
Figure 11:  Europe Vasopressin for Vasoplegic Shock Market Value (US$ Mn), by Application, 2019 & 2027
Figure 12:  Europe Vasopressin for Vasoplegic Shock Market Value Share (%), by Application, 2019
Figure 13:  Europe Vasopressin for Vasoplegic Shock Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027
Figure 14:  Europe Vasopressin for Vasoplegic Shock Market Value Share (%), By Country/ Sub-region, 2019
Figure 15:  Asia Pacific Vasopressin for Vasoplegic Shock Market Value (US$ Mn), by Application, 2019 & 2027
Figure 16:  Asia Pacific Vasopressin for Vasoplegic Shock Market Value Share (%), by Application, 2019
Figure 17:  Asia Pacific Vasopressin for Vasoplegic Shock Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027
Figure 18:  Asia Pacific Vasopressin for Vasoplegic Shock Market Value Share (%), By Country/ Sub-region, 2019
Figure 19:  Latin America Vasopressin for Vasoplegic Shock Market Value (US$ Mn), by Application, 2019 & 2027
Figure 20:  Latin America Vasopressin for Vasoplegic Shock Market Value Share (%), by Application, 2019
Figure 21:  Latin America Vasopressin for Vasoplegic Shock Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027
Figure 22:  Latin America Vasopressin for Vasoplegic Shock Market Value Share (%), By Country/ Sub-region, 2019
Figure 23:  Middle East & Africa Vasopressin for Vasoplegic Shock Market Value (US$ Mn), by Application, 2019 & 2027
Figure 24:  Middle East & Africa Vasopressin for Vasoplegic Shock Market Value Share (%), by Application, 2019
Figure 25:  Middle East & Africa Vasopressin for Vasoplegic Shock Market Value (US$ Mn), By Country/ Sub-region, 2019 & 2027
Figure 26:  Middle East & Africa Vasopressin for Vasoplegic Shock Market Value Share (%), By Country/ Sub-region, 2019
Figure 27:  Global Vasopressin for Vasoplegic Shock Market Share (%), By Company, 2019

Table 1:  Global Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, by Application, 2016–2027
Table 2:  Global Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, by Region, 2016-2027
Table 3:  North America Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, by Application, 2016-2027
Table 4:  North America Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, By Country, 2016-2027
Table 5:  Europe Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, by Application, 2016-2027
Table 6:  Europe Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027
Table 7:  Asia Pacific Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, by Application, 2016-2027
Table 8:  Asia Pacific Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027
Table 9:  Latin America Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, by Application, 2016-2027
Table 10:  Latin America Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027
Table 11:  Middle East & Africa Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, by Application, 2016-2027
Table 12:  Middle East & Africa Vasopressin for Vasoplegic Shock Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2016-2027

 

血管麻痺性ショック市場向けバソプレシン
  • レポートの更新
    進行中
  • 2019-2032
    (進行中)
  • 2024
    (進行中)
無料サンプルをダウンロード

    man icon
    Mail icon
    Captcha refresh
成長アドバイザリーサービス
    新たな機会を発見し、より迅速に拡大できるよう、当社ではどのようなお手伝いをできるでしょうか?
クライアント
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

関連レポート